- Home
- TKNO vs NKTR Comparison
TKNO vs NKTR Comparison
Compare TKNO & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TKNO
- NKTR
- Stock Information
- Founded
- TKNO 1996
- NKTR 1990
- Country
- TKNO United States
- NKTR United States
- Employees
- TKNO N/A
- NKTR N/A
- Industry
- TKNO Medicinal Chemicals and Botanical Products
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- TKNO Health Care
- NKTR Health Care
- Exchange
- TKNO Nasdaq
- NKTR Nasdaq
- Market Cap
- TKNO 340.9M
- NKTR 1.2B
- IPO Year
- TKNO 2021
- NKTR 1994
- Fundamental
- Price
- TKNO $5.13
- NKTR $57.61
- Analyst Decision
- TKNO
- NKTR Strong Buy
- Analyst Count
- TKNO 0
- NKTR 6
- Target Price
- TKNO N/A
- NKTR $91.67
- AVG Volume (30 Days)
- TKNO 372.0K
- NKTR 937.6K
- Earning Date
- TKNO 11-06-2025
- NKTR 11-06-2025
- Dividend Yield
- TKNO N/A
- NKTR N/A
- EPS Growth
- TKNO N/A
- NKTR N/A
- EPS
- TKNO N/A
- NKTR N/A
- Revenue
- TKNO $38,923,000.00
- NKTR $74,934,000.00
- Revenue This Year
- TKNO $9.52
- NKTR N/A
- Revenue Next Year
- TKNO $15.20
- NKTR N/A
- P/E Ratio
- TKNO N/A
- NKTR N/A
- Revenue Growth
- TKNO 11.40
- NKTR N/A
- 52 Week Low
- TKNO $3.94
- NKTR $6.48
- 52 Week High
- TKNO $10.37
- NKTR $63.92
- Technical
- Relative Strength Index (RSI)
- TKNO 48.78
- NKTR 60.53
- Support Level
- TKNO $4.79
- NKTR $53.73
- Resistance Level
- TKNO $5.54
- NKTR $58.40
- Average True Range (ATR)
- TKNO 0.48
- NKTR 3.78
- MACD
- TKNO -0.08
- NKTR -1.17
- Stochastic Oscillator
- TKNO 18.73
- NKTR 51.23
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.